Clinical Trial Update: Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of combining romosozumab and denosumab for postmenopausal osteoporosis with multiple fragility fractures. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Evenity (romosozumab)
• Prolia (denosumab)

Snippet

Sponsor: Marmara University | Conditions: Osteoporosis in Post-menopausal Women | Phase 4 | Status: NOT_YET_RECRUITING